The DUR Board provides evaluation of criteria for drug coverage within Texas Medicaid. These criteria are used in retrospective and prospective drug utilization review, and are based on the compendia and peer reviewed medical literature. Criteria and standards are periodically revised to ensure that they reflect prescribing recommendations of the current compendia and literature.

  1. Acetylcholinesterase Inhibitors (PDF)
  2. Aerosolized Agents - metered-dose inhalers: anticholinergic drugs (PDF)
  3. Aerosolized Agents - metered-dose inhalers: inhaled anti-inflammatory drugs (corticosteroids)
  4. Aerosolized Agents - metered-dose inhalers: beta 2 adrenergic drugs (long-acting)
  5. Aerosolized Agents - metered-dose inhalers: beta 2 adrenergic drugs (short-acting)
  6. Angiotensin-Converting Enzyme Inhibitors (PDF)
  7. Angiotensin II Receptor Blockers (PDF)
  8. Antidepressant Drugs
  9. Antidiabetic Agents (oral) (PDF)
  10. Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications
  11. Atypical Antipsychotics (long-acting injectable) (PDF)
  12. Atypical Antipsychotics (oral) (PDF)
  13. Benzodiazepines (oral, rectal) (PDF)
  14. Complement Inhibitor and Enzyme/Protein Replacement Therapy (PDF)
  15. Cyclooxygenase-2 Inhibitors (PDF)
  16. Direct Oral Anticoagulants (PDF)
  17. Exogenous Insulin Products (PDF)
  18. Fentanyl (PDF)
  19. Fluoroquinolones (oral) (PDF)
  20. Gabapentin (PDF)
  21. Glucagon-like Peptide 1 Receptor Agonists (PDF)
  22. Histamine H2 - Receptor Antagonists (PDF)
  23. Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors (PDF)
  24. Hydrocodone Bitartrate/Hydrocodone Polistirex (PDF)
  25. Immune Globulins (PDF)
  26. Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi) (PDF)
  27. Ketorolac (oral) (PDF)
  28. Leukotriene Receptor Antagonists (PDF)
  29. Low-dose Quetiapine (PDF)
  30. Low Molecular - Weight Heparins (PDF)
  31. Memantine (PDF)
  32. Mecasermin (PDF)
  33. Nebulized Bronchodilators (PDF)
  34. Nitazoxanide (PDF)
  35. Non-sedating Antihistamines (PDF)
  36. Non-steroidal anti-inflammatory drugs (PDF)
  37. Oral Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting (PDF)
  38. Pramlintide
  39. Promethazine Use In Children Less Than 2 Years of Age (PDF)
  40. Proton Pump Inhibitors (PDF)
  41. Rifaximin (Xifaxan)
  42. Sedative/Hypnotics (PDF)
  43. Serotonin 5-HT1B/1D Receptor Agonists (PDF)
  44. Skeletal Muscle Relaxants (PDF)
  45. Substance P/Neurokinin1 Receptor Antagonists (PDF)
  46. Topical Calcineurin Inhibitors - Pimecrolimus (Elidel) and Tacrolimus (Protopic) (PDF)
  47. Tramadol (PDF)